GBS Inc. Gains 67.95%
GBS Inc. (GBS:NASDAQ) soared at $1.31, representing a gain of 67.9%. On Sat, Apr 02, 2022, GBS:NASDAQ touched a New 2-Week Intraday Low of $0.75. The stock appeared on our News Catalysts scanner on Mon, Apr 04, 2022 at 01:13 PM in the 'MISCELLANEOUS' category. From Mon, Mar 21, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Mon, Mar 21, 2022 at $1.25 with a volume of 7M+.
About GBS Inc. (GBS:NASDAQ)
GBS Inc is a United States-based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively.
Top 10 Gainers:
- GBS Inc. (GBS:NASDAQ), 67.95%
- Aterian Inc. (ATER:NASDAQ), 46.78%
- Protalix BioTherapeutics, Inc. (PLX:NYSEMKT), 41.9%
- IO Biotech Inc. (IOBT:NASDAQ), 33.16%
- VirnetX Holding Corp (VHC:NYSE), 31.33%
- Dingdong (Cayman) Limited American Depositary Shares (each two representing three) (DDL:NYSE), 28.77%
- BRC Inc. Class A (BRCC:NYSE), 28.72%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 28.08%
- Twitter, Inc. (TWTR:NYSE), 27.12%
- Jumia Technologies AG (JMIA:NYSE), 24.68%